Dividend-paying biotech stocks, particularly those like AstraZeneca (AZN), provide investors with passive income as well as the possibility of capital appreciation.
A titan in the global healthcare industry, U.K.-based AstraZeneca has established itself as a key player in the race for medical breakthroughs, boasting a diverse portfolio of innovative medicines. The stock has soared 110% in the last 10 years, driven by its triumphs in medical science.
